The Multifactorial Roots of Obesity: Beyond Calories In and Calories Out

Obesity is a costly, complex, and multifaceted condition affecting millions of people worldwide. Traditionally, weight management has been framed in simplistic “calories in, calories out” terms. But, there’s much more to understanding the manifestation of obesity aside from serving sizes and total calories.  Looking at obesity through the root-cause lens is crucial for effective treatment […]

Read more

Ciba Health raises $10M Series A

Ciba Health raises $10M Series A, announces C-suite expansion and growth numbers to transform chronic disease treatment with root-cause approach. Ciba Health announces rapid growth and an expansion to its leadership team on the heels of its $10M Series A funding. Ciba Health raised an oversubscribed $10M Series A funding round led by DigiTx Partners, […]

Read more

4 ways employers and payers can navigate the changing landscape of T2D, obesity and weight management.

In recent years, select GLP-1a drugs have become a common treatment for Type-2 diabetes, and drugs in that class have been approved for weight loss. Utilization of these drugs have been driven by social media influencers and advertising. Combined with the fact that more than 41% of U.S. adults identified as obese, the demand for […]

Read more

Ciba Health Partners with Stonebrook Risk Solutions to provide access to chronic disease reversal to millions of Americans.

New York, 08/30/2013 – Ciba Health, a global innovator in digital health and value-based care has announced a partnership with Stonebrook Risk Solutions. This collaboration aims to deliver access to Ciba Health’s comprehensive chronic disease reversal solutions to potentially millions of Americans suffering from chronic conditions, revolutionizing the way chronic conditions are treated and managed. […]

Read more

Ciba Health opening a new office in Canada

Ciba Health is announcing the opening of a new office in Edmonton as the next step in the company’s global expansion. Supported by Alberta Innovates and Edmonton Global to launch operations in Edmonton, AB, Ciba Health will be bringing expertise in digital therapeutics, AI and chronic disease reversal to the region. It will enhance the […]

Read more

Revolutionary Approach to Healthcare: The Case of Reversing Obesity and Related Chronic Diseases

The US healthcare system spends almost $173 billion annually on obesity-related costs, making it a priority issue for the healthcare sector. Over the past few years, the healthcare sector has been heavily focused on creating and promoting drugs for diabetes and weight loss. Despite the massive amount of capital invested in these drugs, healthcare expenses […]

Read more

We are proud to announce that Sharon A. Williams has joined the Ciba Health team as a Strategic Adviser.

Read more

LG NOVA Selects Companies, Entrepreneurs for Second Annual Mission for the Future Program

Of 2,170 submissions, including 752 in digital health, Ciba Health is among the top 20 that have been officially selected for LG NOVA’s second annual Mission for the Future ’22 Global Search for innovative concepts and transformative solutions for people and the planet. The Mission for the Future Global Search is a program hosted by […]

Read more

The CDC recognizes and approves Ciba Health’s diabetes prevention program to be used in the National Diabetes Prevention Program (DPP)

NEW YORK, September 20, 2022 – Ciba Health, best known for its innovative Prediabetes/Diabetes Reversal Programs, has been recognized and approved by the Centers for Disease Control and Prevention (CDC) as part of the National Diabetes Prevention Program (DPP) – the federally backed effort to prevent diabetes in Americans). According to CDC estimates, 1 in […]

Read more

Obesity is a costly, complex, and multifaceted condition affecting millions of people worldwide. Traditionally, weight management has been framed in simplistic “calories in, calories out” terms. But, there’s much more to understanding the manifestation of obesity aside from serving sizes and total calories. 

Looking at obesity through the root-cause lens is crucial for effective treatment because it fosters a deeply-personalized targeted approach for weight loss results that last. Obesity isn’t a matter of overeating or lack of exercise. It’s driven by the more complicated interplay of factors that vary among individuals, such as:

Genetics

Hormone imbalances

Gut health issues

Psychological factors that lead to emotional eating

By identifying and addressing root causes, healthcare providers can develop more effective and individualized treatment plans that go beyond “eat more, move less.”They can tackle the specific genetic, biochemistry-driven, lifestyle factors contributing to challenges with weight and health. 

Let’s look at some of these factors that contribute to obesity more closely. 

Genetic Factors

Genetics play a crucial role in determining an individual’s susceptibility to obesity. Research has identified numerous genes associated with obesity, each contributing in different ways to weight regulation.

Genetic Predisposition

Some individuals are genetically predisposed to gain weight more easily than others. Studies have shown that variations in specific genes, such as the FTO gene, are linked to increased body mass index (BMI) and obesity risk. These genetic variations can affect hunger, satiety, and how the body stores and utilizes fat.

Epigenetics

Epigenetics involves changes in gene expression without altering the DNA sequence. Environmental factors, such as diet and exposure to toxins, can cause epigenetic modifications that may predispose individuals to obesity. For example, maternal nutrition during pregnancy can influence the child’s risk of developing obesity later in life by altering the expression of genes involved in metabolism.

Gene-Environment Interaction

The interaction between genetic predisposition and environmental factors is critical. For instance, individuals with a genetic tendency to store fat may be more susceptible to obesity in environments where high-calorie foods are readily available. This interplay underscores the importance of considering both genetic and environmental influences when addressing obesity.

Environmental Factors

The modern environment plays a significant role in the obesity epidemic. Urbanization, technological advancements, and the proliferation of processed foods contribute to an obesogenic environment.

Food Environment

The availability and marketing of high-calorie, nutrient-poor foods are major contributors to obesity. Fast food restaurants, sugary beverages, and processed snacks are ubiquitous, making unhealthy choices more accessible and appealing. Portion sizes have also increased, leading to higher calorie consumption.

Built Environment

Urbanization and changes in the built environment have reduced opportunities for physical activity. Many neighborhoods lack safe spaces for walking, cycling, and recreation. Additionally, sedentary behaviors, such as prolonged screen time, have become more prevalent due to technological advancements.

Socioeconomic Factors

Socioeconomic status significantly influences obesity risk. Lower-income individuals often face barriers to healthy eating and physical activity, such as limited access to fresh produce and safe exercise spaces. Food insecurity can lead to poor dietary choices and overeating when food is available, contributing to weight gain.

Psychological and Behavioral Factors

Psychological and behavioral factors are deeply intertwined with obesity. Stress, emotional eating, and behavioral patterns play a critical role in weight management.

Stress and Emotional Eating

Stress and emotional distress can lead to overeating and poor food choices. Many individuals turn to food for comfort, consuming high-calorie, sugary, or fatty foods that provide temporary relief but contribute to weight gain over time. Chronic stress also increases levels of cortisol, a hormone that promotes fat storage, particularly around the abdomen.

Sleep Patterns

Sleep deprivation is linked to obesity. Lack of sleep disrupts hormonal balance, increasing levels of ghrelin (which stimulates appetite) and decreasing levels of leptin (which signals satiety). This hormonal imbalance can lead to increased hunger and overeating.

Behavioral Patterns

Unhealthy behaviors, such as irregular eating schedules, skipping meals, and consuming large portions, contribute to obesity. Habits developed during childhood, such as preference for sugary snacks and sedentary activities, can persist into adulthood, making weight management more challenging.

Challenges of obesity treatment today

The current approach to treating obesity often relies on a combination of lifestyle modifications, pharmacotherapy, and in some cases, bariatric surgery. 

Lifestyle modifications typically include:

Pharmacotherapy usually involves the use of medication to:  

Bariatric surgery, such as gastric bypass or sleeve gastrectomy, is usually reserved for individuals with severe obesity who have not responded to other treatments. While these methods can be effective, they often fall short for many individuals due to several intrinsic and extrinsic factors.

One major reason the current approach often doesn’t work is its reliance on self-motivation and sustained behavioral change, which are difficult to maintain over the long term. Many patients struggle with adherence to restrictive diets and regular exercise routines, especially in an environment that promotes unhealthy food choices and sedentary lifestyles. 

Moreover, the psychological and emotional aspects of obesity, such as stress, depression, and stigma, are frequently under addressed. These factors can lead to emotional eating and trouble sustaining motivation, which undermine efforts to lose weight.

Pharmacotherapy, while helpful for some, also has its limitations. Weight loss medications often come with side effects and may only be effective while the medication is being taken. Once the medication is stopped, individuals frequently regain the weight, highlighting the challenge of achieving sustainable weight loss through pharmacological means alone. 

Similarly, bariatric surgery, although it can result in significant weight loss, is not a universal solution. It carries risks and requires a lifelong commitment to dietary changes and regular medical follow-up. Additionally, not all patients qualify for surgery or have access to it due to cost or other barriers.

Furthermore, the current approach tends to treat obesity as a uniform condition, rather than recognizing the individual variability in its causes and manifestations. Without a tailored approach that addresses the specific genetic, metabolic, psychological, and socio-economic factors of each patient, treatment plans are often less effective. 

Future Directions in Obesity Treatment

The future of obesity treatment lies in advancing our understanding of the root causes of obesity and adopting a personalized approach to treatment. This involves comprehensive root-cause analysis to identify and address the unique factors contributing obesity on a person-by-person basis. By doing so, healthcare providers can develop tailored treatment plans that are more effective and sustainable for the long term.

Root-cause analysis in obesity treatment involves a thorough examination of the various genetic, metabolic, psychological, and environmental factors that contribute to weight gain.

Genetic testing can reveal predispositions to obesity, such as variations in genes related to appetite regulation, fat storage, and metabolism. Understanding these genetic factors can help identify individuals who may benefit from specific interventions, such as targeted medications or personalized dietary plans. Additionally, metabolic assessments can provide insights into how an individual’s body processes and stores energy, guiding more effective dietary and exercise recommendations.

A personalized approach to obesity treatment also involves identifying and addressing individual triggers.

For some, psychological factors such as stress, anxiety, or depression may be significant contributors to their weight gain. Incorporating mental health support, such as cognitive-behavioral therapy or stress management techniques, can be crucial for these individuals.

For others, environmental factors such as access to healthy foods and opportunities for physical activity may play a larger role. In these cases, interventions might focus on improving the food environment, increasing physical activity opportunities, and addressing socio-economic barriers.

Advances in technology and data analytics also play a pivotal role in the future of personalized obesity treatment. Wearable devices and mobile health apps can provide real-time data on physical activity, dietary intake, and other health metrics, allowing for continuous monitoring and personalized feedback. Machine learning algorithms can analyze this data to identify patterns and predict which interventions are likely to be most effective for each individual.

Connection between gut health and obesity

Gut health plays a significant role in the development and management of obesity. The gut microbiome, composed of trillions of microorganisms living in the digestive tract, influences how the body processes food, stores fat, and regulates appetite. 

Imbalances in the gut microbiome, known as dysbiosis, have been linked to increased fat storage, insulin resistance, and inflammation, all of which contribute to obesity. Research suggests that individuals with obesity often have a less diverse gut microbiome compared to those with a healthy weight.

Improving gut health can be a key strategy in obesity treatment. Probiotics, prebiotics, and dietary changes aimed at increasing the diversity and balance of gut bacteria can help regulate metabolism and reduce inflammation. For instance, a diet rich in fiber from fruits, vegetables, and whole grains supports the growth of beneficial bacteria, which can aid in weight management. Additionally, certain strains of probiotics have been found to promote weight loss and improve metabolic health, making them a potential therapeutic tool in obesity treatment.

Personalized approaches to enhancing gut health are becoming increasingly important. Since the composition of the gut microbiome varies significantly between individuals, treatments must be tailored to each person’s unique microbial profile. 

Advances in microbiome sequencing technology allow for detailed analysis of an individual’s gut bacteria, enabling healthcare providers to recommend specific dietary and probiotic interventions. By focusing on gut health as a central component of obesity treatment, it is possible to address one of the root causes of weight gain and improve overall health outcomes.

Join our webinar on June 12 at 1:00 PM ET to learn more about how gut health plays a role in obesity, and how taking a root-cause approach to weight loss can improve health outcomes and drive down costs for everyone.
Register: https://us02web.zoom.us/webinar/register/WN_qA5diLVYQm-FBifq4eSFZg

Ciba Health raises $10M Series A, announces C-suite expansion and growth numbers to transform chronic disease treatment with root-cause approach.

Ciba Health announces rapid growth and an expansion to its leadership team on the heels of its $10M Series A funding. Ciba Health raised an oversubscribed $10M Series A funding round led by DigiTx Partners, with participation from E12 Ventures, 3CC Capital, Plug and Play Ventures and angel investors. The company also appointed Nwamaka Imasogie, formerly a Principal Software Engineer on the healthcare AI team at Microsoft, as Chief Technology Officer. Roger Chahine has been promoted from Chief Strategy and Operating Officer to President. Imasogie and Chahine bring extensive technology and healthcare experience to their roles, which will help to solidify Ciba Health as the leader in whole person-care that is changing traditional healthcare with a root-cause approach.

Ciba Health is revolutionizing the prevention and treatment of chronic diseases through expert care teams, lab testing and a root-cause approach to understand and solve core issues that in turn, treat a variety of conditions including type 2 diabetes, digestive health issues and more. The company is using the funds to accelerate product development and scale its operations to meet growing market demand. Ciba Health fills in gaps between a patient’s primary providers and specialists to create a comprehensive, customized program for its users. Its onboarding process includes a questionnaire and easy clinical tests which identify over 300 lab markers, compared to the average 50 markers in traditional tests. Each patient is matched with a provider team, which includes 1:1 visits with a health coach, physician and dietician, and given wearable devices like Fitbits and sleep trackers not normally offered in the healthcare market, to understand their conditions and treat the root causes with accessibility, transparency, convenience and comfort. Ciba Health contracts with employers as a benefit and also is accessible for individual adults and dependents. Ciba Health is currently offered to more than 97k individuals, and the company boasts a 98% provider retention rate. The company has seen a 100% revenue growth YoY and a 300% growth in patients on the platform YoY since its inception in 2020. 

“We are thrilled to have secured this investment from such a respected group of investors,” said Dr. Innocent Clement, CEO of Ciba Health. “Their support validates our vision and commitment to creating a healthcare system with no gaps, so patients and their providers have all the information needed to treat and reverse chronic diseases with a more holistic approach. We will leverage this funding to drive the growth of our platform and make a meaningful impact on the lives of patients worldwide through a root-cause medicinal approach.”

Prior to joining Ciba Health, Imasogie served as Chief Technology Officer at an AI medical software company, where she created its minimal viable product in less than three months which was used on patients in a full clinical trial, before launching her own business for startups and private equity companies. In her role as Chief Technology Officer, Imasogie will implement algorithms, systems and processes to fuel scalability, ensuring a seamless and pleasant experience for everyone who uses the Ciba Health platform. As President, Chahine, who also was a Founding Partner at early-stage venture capital firm Day223 Ventures, will lead Ciba Health’s business building activities and operations across all functions, while also spearheading the company’s expansion into international markets.

“I’m proud to join a team so committed to connecting the dots that are currently missing from traditional healthcare,” said Nwamaka Imasogie, Chief Technology Officer of Ciba Health. “As Ciba Health is paving the way in scaling root-cause medicine to redefine healthcare with its in-depth lab testing and transparency, I look forward to working alongside a dedicated team of experts to improve the wellbeing of those living with chronic diseases.”

“We are excited to support Innocent and his team as they continue to help patients suffering from chronic diseases with a highly engaging and scalable solution,” said Miraj Sanghvi, Partner at DigiTx Partners. “We always aim to support healthcare companies changing outcomes for their customers. Ciba Health’s unique offerings are tailored to not only change patients’ lives, but save them, and we believe that Ciba Health is the platform that is changing the future of health.”

Ciba Health recently launched its Pediatric Metabolic Program in March to offer its health plans to children five and older as well as their families. The company has also partnered with Instacart Health to integrate Instacart’s grocery shopping offering with Ciba Health’s dietician services and nutrition program, and also joined Solera Health’s network to help employers offer foundational medical treatment at an affordable cost. Ciba Health is revolutionizing the digital health sector by making it as high touch as it is high technology. The company plans to expand its partnerships with third party administrators, integrate GLP-1 step therapies into its employer offerings, PBMs and health plans, and continue building its employee headcount in the coming months.

In recent years, select GLP-1a drugs have become a common treatment for Type-2 diabetes, and drugs in that class have been approved for weight loss. Utilization of these drugs have been driven by social media influencers and advertising. Combined with the fact that more than 41% of U.S. adults identified as obese, the demand for GLP-1a drugs for weight loss has increased exponentially.

According to a recent Prime Therapeutics study, among those individuals who initiated GLP-1 drugs for weight loss at one year follow-up, those patients had a significantly higher total cost of care, at $7,727 per person. Adherence to these drugs was just 27% of individuals taking GLP-1 drugs after one year. Among GLP-1 adherent individuals, the increase in costs was even higher, double that of the matched controls, at $13,218 higher total cost of care per person.

Prime forecasts that an increase of GLP-1a weight loss utilization by 1% of an insured population would bring an additional $14.50 per member per month (PMPM) expense for most self-insured employers – an increase of more than 5% of their entire drug spend budget.  

On top of the cost consideration, relying solely on medicine is insufficient. Obesity and type 2 diabetes treatment is an intricate process with numerous obstacles that could impact its efficacy. To build a truly effective and cost-effective plans for members here are four specific areas that employers and payers can concentrate on:

1. Prevention. 

Preventing obesity from developing in the first place is critical, as it eliminates the need for costly medical interventions and treatments down the line.

Investing resources in prevention programs is an astute strategy that can lead to significant improvements in health outcomes, especially for high-risk groups. Such programs can include education about healthy eating habits, exercise and fitness regimes, and access to support systems such as professional counseling or community support groups. In addition, employers can encourage physical activity and healthy lifestyles by offering discounted gym memberships, introducing healthy eating options in the workplace, and creating a culture of wellness.

Preventing obesity can thus lead to significant savings for payers and employers, reducing the burden on healthcare and insurance systems. According to a study by the Robert Wood Johnson Foundation, an investment of $10 per person per year in community-based prevention programs can result in net savings of more than $16 billion over ten years, resulting from reduced healthcare costs and improved productivity.

Furthermore, preventive measures can also improve overall quality of life for individuals, leading to greater happiness and well-being. Focusing on prevention equips individuals with the knowledge and tools they need to make better lifestyle choices, leading to a healthier society as a whole.

2. Behavioral Change.

Studies have shown that behavioral change programs can produce long-lasting results by addressing the root causes of weight gain and diabetes. Behavioral change programs employ several techniques to motivate individuals towards their desired goals. 

Self-monitoring, goal-setting, and positive reinforcement are some of the most effective strategies utilized in these programs. By tracking food intake, physical activities, and behavior changes, participants can analyze their progress and adjust their plans accordingly. Additionally, setting achievable goals and celebrating milestones increases participants’ confidence, making it easier for them to maintain healthy habits.

3. Whole-Health, Root-Cause Approach.

Instead of investing in expensive drugs, employers and healthcare plans are increasingly prioritizing helping people target the underlying reasons for their weight gain and chronic disease. This requires a personalized, precision-based approach that considers each person’s unique biology and lifestyle. Ciba Health’s root-cause methodology is a prime example of such an approach, using cutting-edge technologies such as AI and precision medicine to create tailored care plans and lifestyle strategies that address the underlying causes of cellular dysfunction. 

The Ciba Health approach eliminates the need for GLP1 drugs and improves overall health while effectively saving the healthcare industry millions of dollars.  

4. Step Therapy and/or Prior Authorization for Medications.

While medications can provide relief to those who truly need it, over-reliance on medication can actually exacerbate chronic conditions and cause additional health problems. There is a growing trend among employers and payers to encourage the population to reverse their chronic conditions using the whole-health root-cause approach before turning to medications.  

One example of this growing trend is the use of Ciba Health’s “Type 2 Diabetes Reversal Program” and “Prediabetes, Obesity and Weight Management Program” as a step therapy to accessing GLP-1 medications. This means that in order to be authorized to use costly medications that fail to address the root cause of the disease, patients must first enroll in and complete a root-cause program that has a success rate of 98% in reversing the conditions and associated weight issues without medication. 

As a result, employers and payers can enjoy financial cost-effectiveness without compromising employee or members  access to the care they need. And with Ciba Health’s sustainable and effective care mission, everyone comes out ahead.

In a world where healthcare costs are skyrocketing, obesity and chronic conditions are becoming increasingly common, taking a sustainable root-cause approach is becoming more and more necessary. By focusing on the root cause of disease and working to address it in a holistic manner, patients can achieve long-term success and improved health outcomes, while also reducing the burden on employers and payers.

New York, 08/30/2013 – Ciba Health, a global innovator in digital health and value-based care has announced a partnership with Stonebrook Risk Solutions. This collaboration aims to deliver access to Ciba Health’s comprehensive chronic disease reversal solutions to potentially millions of Americans suffering from chronic conditions, revolutionizing the way chronic conditions are treated and managed.

Ciba Health is known for its personalized approach to healthcare, utilizing cutting-edge technology and a whole-person health methodology to prevent, treat, and reverse chronic conditions effectively. With a range of root-cause programs addressing type 2 diabetes, digestive health, obesity, depression and anxiety, and advanced primary care, Ciba Health is focused on addressing the underlying causes of diseases rather than just managing symptoms.

Stonebrook Risk Solutions is building an integrated platform  for health plans and TPA’s as an alternative to the large national  health plans. Stonebrook’s digital platform allows best-in-class providers, such as Ciba Health, to connect  via API and combine their services into compelling offerings that aim to reverse the trend of rising health care costs while drastically improving outcomes. By offering employers, brokers, and consultants a higher quality option, Stonebrook aims to disrupt the industry and provide superior care with better options and better pricing. 

“We are thrilled to partner with Stonebrook Risk Solutions in our shared mission to transform chronic disease care,” said Dr. Innocent Clement, CEO of Ciba Health. “By integrating our comprehensive chronic disease reversal solutions with Stonebrook’s innovative approach, we aim to revolutionize healthcare delivery and empower employers and individuals to take control of their healthcare options like never before”. 

By harnessing the power of data from medical history, labs, and connected devices, Ciba Health’s proprietary methodology enables a personalized and whole-person approach to healthcare. Each patient is assigned a dedicated team of providers – including health coaches, dietitians, and physicians – who work collaboratively to create personalized health plans and provide ongoing support. Through the partnership with Stonebrook, Ciba Health will provide advanced chronic disease solutions to a broader population at risk. 

“Stonebrook’s goal is to organize a best-in-class team of partners all of whom focus on medical management and controlling the cost of the care.” said Mark Angard, Chief Executive Officer of Stonebrook Risk Solutions. “With its unique chronic disease reversal approach, Ciba Health represents the best example of a cost containment company that adds value to the ecosystem bringing valuable savings to our clients and members of the health plan. Additionally, Ciba Health’s responsiveness and willingness to join our ecosystem have made it a positive business opportunity for both sides”.

For more information about Ciba Health and its revolutionary chronic disease reversal solutions, visit their website at [cibahealth.com]. To learn more about Stonebrook Risk Solutions and their integrated national health plan, please visit [stonebrookrisk.com].

Ciba Health Ciba Health is a global digital health and value-based care platform focused on preventing, treating, and reversing chronic conditions through a whole-person health approach. Their cutting-edge technology and personalized programs empower individuals to take control of their health, reverse chronic diseases and improve overall well-being.

Stonebrook Risk Solutions Stonebrook Risk Solutions is building an integrated national health plan as an alternative to traditional providers, offering superior care and better pricing. Their innovative approach aims to disrupt the industry by creating a cohesive ecosystem that integrates best-in-class providers and delivers compelling healthcare solutions to employers, brokers, and consultants.

Please note: The information provided in this press release is based on the context and sources available at the time of writing. Any specific details or updates regarding the partnership between Ciba Health and Stonebrook Risk Solutions should be obtained from official announcements or by contacting the respective organizations directly.

Ciba Health is announcing the opening of a new office in Edmonton as the next step in the company’s global expansion. Supported by Alberta Innovates and Edmonton Global to launch operations in Edmonton, AB, Ciba Health will be bringing expertise in digital therapeutics, AI and chronic disease reversal to the region. It will enhance the growth of the Edmonton health and life science sector, strengthen Canada’s tech ecosystem, and help serve patients dealing with type 2 diabetes. 

“We are very excited to welcome Ciba Health into the Edmonton Metropolitan Region. Ciba Health will bring new innovations to our health and life sciences sector — an extremely valuable addition to our strong and growing ecosystem.” said Malcolm Bruce, CEO of Edmonton Global. “We have world-class facilities like the Alberta Diabetes Institute to support diabetes research and precision health, and Ciba Health will help this industry thrive, lower hospital visits, and get Canadians the care they need. We look forward to what contributions will come from Ciba Health’s leadership in the Edmonton region.”

Utilizing artificial intelligence for predictive medicine, Ciba Health has chosen the Edmonton region due to its well-developed health and life science sector with plenty of room for growth within North America. The company aims to hire from 15 to 20 employees in the first year in Alberta and double the size of the team in the second year of operations. This investment will play a role in reduced hospital visits and increased R&D opportunities for life sciences. Ciba Health plans to initially be located at the Health Innovation Hub. 

“We are excited to continue our global expansion in Canada, particularly in Edmonton, Alberta. We definitely see the need for our solutions, especially the Type 2 Diabetes Reversal and the Prediabetes, Obesity & Weight Loss Programs.” shared Ciba Health’s CEO Dr. Innocent Clement. “We truly believe that our innovative product will improve quality of life, enhance healthcare, and empower the fight against chronic diseases in a much more efficient way. We are happy to be able to count on partners such as Edmonton Global, Alberta Innovates, and Plug and Play Alberta to continue our journey and be part of such a welcoming and innovative ecosystem.” 

Alberta Innovates, Plug and Play Alberta and Edmonton Global have been working to support Ciba Health’s expansion plans by providing insights about the local business landscape and making valuable introductions to service providers and partners. 

The US healthcare system spends almost $173 billion annually on obesity-related costs, making it a priority issue for the healthcare sector. Over the past few years, the healthcare sector has been heavily focused on creating and promoting drugs for diabetes and weight loss. Despite the massive amount of capital invested in these drugs, healthcare expenses have continued to increase, and adverse side effects from inadequate treatments are becoming more widespread. As a result, there has been a growing recognition that these solutions do not address the root causes of weight gain and chronic disease, nor do they offer sustainable, long-lasting solutions for individuals struggling with these conditions.

Instead of investing in expensive drugs, employers and healthcare plans are increasingly prioritizing helping people target the underlying reasons for their weight gain and chronic disease. This requires a personalized, precision-based approach that considers each person’s unique biology and lifestyle. Ciba Health’s root-cause methodology is a prime example of such an approach, utilizing precision medicine, cutting-edge technologies, such as AI to create tailored care plans and lifestyle strategies that address the underlying causes of cellular dysfunction.

This approach eliminates or reduces the need for medications and lowers the costs and side effects associated with these drugs, resulting in significant cost savings for employers and payers. 

While medications can provide relief to those who truly need it, over-reliance on medication can actually exacerbate chronic conditions and cause additional health problems. Thus, there is a growing trend among employers and payers to encourage the population to reverse their chronic conditions utilizing the whole-health, root-cause approach before turning to medications.  

One example of this growing trend is the use of Ciba Health’s “Type 2 Diabetes Reversal Program” and “Prediabetes, Obesity and Weight Loss Program” as prior authorization to accessing medication. This means that in order to be authorized to use costly medications that fail to address the root cause of the disease, patients must first enroll in and complete a root-cause program that has a success rate of 98% in reversing the conditions and associated weight issues without medication. 

Employers and payers can enjoy financial cost-effectiveness without compromising employee or members access to the care they need. With Ciba Health’s sustainable and effective care solutions, everyone comes out ahead.

It’s time to take a stand against skyrocketing healthcare costs and the growing prevalence of obesity and chronic conditions. As more patients, employers and health plans embrace a whole-health, root-cause approach, it becomes evident that addressing the underlying causes of diseases in a holistic manner will achieve long-term success, cut costs and improve health outcomes. Join Ciba Health in promoting this life-changing approach and contributing to a healthier future for all.

Learn more about the Ciba Health’s Prediabetes, Obesity and Weight Loss Program.

Of 2,170 submissions, including 752 in digital health, Ciba Health is among the top 20 that have been officially selected for LG NOVA’s second annual Mission for the Future ’22 Global Search for innovative concepts and transformative solutions for people and the planet. The Mission for the Future Global Search is a program hosted by LG NOVA, LG Electronics’ North American Innovation Center, to find promising businesses for collaboration with LG to jointly develop new solutions to improve quality of life and build a better future.

As a part of this program, Ciba Health may qualify for pilot programs with LG NOVA, and potential investments from LG Electronics, LG Display, and other LG NOVA affiliates.

Click here to learn more about the Mission for the Future.

NEW YORK, September 20, 2022 – Ciba Health, best known for its innovative Prediabetes/Diabetes Reversal Programs, has been recognized and approved by the Centers for Disease Control and Prevention (CDC) as part of the National Diabetes Prevention Program (DPP) – the federally backed effort to prevent diabetes in Americans).

According to CDC estimates, 1 in 3 American adults — about 87 million people — has prediabetes. If left untreated, 40% of all American adults will be diagnosed with type 2 diabetes. The cost of care for those with diabetes now accounts for approximately 1 in 4 healthcare dollars spent in the United States.

“Being recognized and approved by the CDC, and included in the National DPP program, means Ciba Health’s novel diabetes programs can reach and help even more Americans suffering from this chronic disease. Chronic illness prevention is one of the biggest challenges of our generation. With this greater reach, more Americans will be able to take advantage of preventive medicine,” said Ciba Health’s Chief Executive Officer, Dr. Innocent Clement. “Ciba Health has demonstrated preventive success in patients exhibiting the precursors to diabetes, plus reversing type 2 diabetes for those who are already diagnosed. CDC approval and support is clearly an important step in our journey.”

Ciba Health uses an individual’s biochemistry to treat their underlying disease, as they understand no two patients are alike. This comprehensive whole-person health approach is designed to get to the root cause of chronic conditions, reduce/eliminate the need for medications, increase energy, improve sleep, and reverse disease.

“We, at SPS Companies, are very excited to offer Ciba’s whole-person, root-cause health solutions to our employees. We started with the Type 2 Diabetes Reversal Program in 2022 and are excited to expand our partnership with Ciba Health by integrating additional precision medicine solutions into our programs. We take the health of our employees very seriously and want to give our employees every tool possible to help them realize and sustain ever-improving health. We truly believe that Ciba Health’s innovative programs can prevent and treat chronic diseases among our employees.” says Corey Kephart, Vice President of Human Resources at SPS Companies.

About DPP

The CDC’s National Diabetes Prevention Program (National DPP) is a partnership of public and private organizations working to prevent or delay type 2 diabetes. Partners make it easier for people at risk for type 2 diabetes to participate in evidence-based lifestyle change programs to reduce their risk of type 2 diabetes.

About Ciba Health

Ciba Heath (cibahealth.com) was established in 2019, with the mission of improving health through precision and personalized medicine. Initially focused on Pre & type 2 diabetes reversal, Ciba has grown its portfolio of products to include Advanced Primary Care, Depression & Anxiety, and Digestive Health. Offering tailored health programs to its patients, Ciba addresses the root cause of a disease with its team of doctors, psychiatrists, health coaches, and nutritionists, leveraging cutting-edge technology for predictive analytics, remote patient monitoring, and digital therapeutic devices for real-time data monitoring.